• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday

    11/30/23 10:12:50 AM ET
    $BCYC
    $CMPS
    $CRM
    $EVER
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BCYC alert in real time by email

    U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.

    Shares of La-Z-Boy Incorporated (NYSE:LZB) moved higher on Thursday as the company reported upbeat earnings results for its second quarter and increased its quarterly cash dividend by 10%.

    La-Z-Boy posted adjusted earnings of 74 cents per share, beating market estimates of 62 cents per share. The company’s quarterly sales came in at $511.44 million versus estimates of $502.33 million.

    La-Z-Boy shares gained 7.5% to $34.08 on Thursday.

    Here are some other big stocks recording gains in today’s session.

    • ImmunoGen, Inc. (NASDAQ:IMGN) shares surged 80% to $28.89 after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash.
    • REX American Resources Corporation (NYSE:REX) shares rose 30.7% to $48.22 following strong third-quarter results.
    • Zuora, Inc. (NASDAQ:ZUO) climbed 19.5% to $9.98 after the company reported better-than-expected third-quarter financial results and issued guidance.
    • SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) rose 18.3% to $31.75.
    • The InterGroup Corporation (NASDAQ:INTG) climbed 13.7% to $25.50.
    • Victoria's Secret & Co. (NYSE:VSCO) surged 13.6% to $26.80 following third-quarter results.
    • VinFast Auto Ltd. (NASDAQ:VFS) rose 11.7% to $8.44 after gaining around 8% on Wednesday.
    • Farfetch Limited (NYSE:FTCH) gained 11.2% to $1.0842.
    • Bicycle Therapeutics plc (NASDAQ:BCYC) rose 11% to $15.01.
    • MorphoSys AG (NASDAQ:MOR) surged 10.7% to $6.59.
    • QuinStreet, Inc. (NASDAQ:QNST) gained 10.4% to $12.67. B. Riley Securities upgraded QuinStreet from Neutral to Buy and raised the price target from $11 to $19.
    • Salesforce, Inc. (NYSE:CRM) shares climbed 8.4% to $249.69 after the company reported third-quarter financial results and issued FY24 guidance above estimates.
    • EverQuote, Inc. (NASDAQ:EVER) gained 7.8% to $10.33. B. Riley upgraded EverQuote from Neutral to Buy and raised the price target from $8 to $14.
    • Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) rose 7.7% to $2.9397.
    • Oatly Group AB (NASDAQ:OTLY) rose 7.5% to $1.0750.
    • Snowflake Inc. (NYSE:SNOW) surged 7.1% to $187.76 after the company reported better-than-expected third-quarter financial results and issued guidance.
    • Snap Inc. (NYSE:SNAP) rose 6.6% to $13.85 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $12 to $16.
    • PVH Corp. (NYSE:PVH) gained 6.2% to $97.16 following upbeat earnings.
    • COMPASS Pathways plc (NASDAQ:CMPS) gained 6.2% to $6.30.
    • Nutanix, Inc. (NASDAQ:NTNX) gained 5% to $43.61 after the company reported better-than-expected first-quarter financial results and raised FY24 revenue guidance.

     

    Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Tech Stocks Delivering High-Dividend Yields

    Get the next $BCYC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BCYC
    $CMPS
    $CRM
    $EVER

    CompanyDatePrice TargetRatingAnalyst
    Snap Inc.
    $SNAP
    4/14/2026$7.00 → $6.00Hold
    Canaccord Genuity
    Petco Health and Wellness Company Inc.
    $WOOF
    4/13/2026$3.83Buy → Neutral
    Goldman
    Nutanix Inc.
    $NTNX
    4/10/2026$44.00Overweight → Neutral
    Analyst
    Nutanix Inc.
    $NTNX
    4/3/2026$60.00Buy
    Rosenblatt
    Nutanix Inc.
    $NTNX
    4/2/2026$60.00Buy
    Rosenblatt
    PVH Corp.
    $PVH
    3/24/2026$82.00 → $74.00Market Perform
    Telsey Advisory Group
    Nutanix Inc.
    $NTNX
    3/23/2026Outperform → Mkt Perform
    William Blair
    QuinStreet Inc.
    $QNST
    3/17/2026$17.00Outperform
    Northland Capital
    More analyst ratings

    $BCYC
    $CMPS
    $CRM
    $EVER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity reiterated coverage on Snap with a new price target

    Canaccord Genuity reiterated coverage of Snap with a rating of Hold and set a new price target of $6.00 from $7.00 previously

    4/14/26 1:08:30 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Petco Health and Wellness downgraded by Goldman with a new price target

    Goldman downgraded Petco Health and Wellness from Buy to Neutral and set a new price target of $3.83

    4/13/26 8:44:31 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Nutanix downgraded by Analyst with a new price target

    Analyst downgraded Nutanix from Overweight to Neutral and set a new price target of $44.00

    4/10/26 8:30:04 AM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    $BCYC
    $CMPS
    $CRM
    $EVER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EverQuote to Announce First Quarter 2026 Financial Results on May 4, 2026

    CAMBRIDGE, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (NASDAQ:EVER), a leading online insurance marketplace, today announced that it will report first quarter financial results after the market close on Monday, May 4, 2026. Management will host a conference call and webcast to discuss the Company's financial results, recent developments, and business outlook at 4:30 p.m. ET. What:EverQuote First Quarter 2026 Financial Results Conference Call  When:Monday, May 4, 2026  Time:4:30 p.m. ET  Live Call:US Toll Free: +1 (833) 461-5787All Other: +1 (585) 542-9983Conference ID: 161347139  Live Webcast and Replay:http://investors.everquote.com/   About EverQuote EverQuote (NASDAQ:EVE

    4/14/26 4:05:00 PM ET
    $EVER
    Computer Software: Programming Data Processing
    Technology

    VinFast EVs Bring Back the Joy of Driving as Fuel Costs Climb

    As gas prices climb, Canadian drivers are rediscovering the simple pleasure of driving, with VinFast EVs offering a quieter, smoother ride and freedom from constant fuel concerns. When gas prices went up sharply in the past few weeks, Edric, a Quebec-based freelance photographer who often drives between cities for assignments and who has a special fondness for the open road, knew he had to do something to keep his love alive. It was then that a piece of news caught his eye: EV owners are protected five times more than ICE.1 Intrigued, he went on the web digging for an affordable EV deal and finally, after several calls and trips to the showrooms, which turned out, in hindsight, to be hi

    4/14/26 8:17:00 AM ET
    $VFS
    Auto Manufacturing
    Industrials

    Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training

    Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based organizations to apply for a grant to create training content for healthcare providers to deliver investigational COMP360 psilocybin treatment, if approved. Many high-quality training organizations already exist and have trained thousands of HCPs in core and psilocybin-specific psychedelic care. This grant program was established to support the development of high-quality training content, including a COMP360-specific module, with the aim of ensuring HCPs are well-prepared to care for patients receivi

    4/14/26 6:30:00 AM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BCYC
    $CMPS
    $CRM
    $EVER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk David Blair bought $500,722 worth of shares (1,936 units at $258.64), increasing direct ownership by 22% to 10,677 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    12/18/25 5:10:12 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Morfit G Mason bought $25,015,680 worth of shares (96,000 units at $260.58) (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    12/8/25 9:30:14 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Kirk David Blair bought $865,827 worth of shares (3,400 units at $254.66), gifted 4,278 shares and received a gift of 4,278 shares, increasing direct ownership by 1,811% to 8,102 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    9/10/25 7:45:16 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $BCYC
    $CMPS
    $CRM
    $EVER
    SEC Filings

    View All

    SEC Form 6-K filed by VinFast Auto Ltd.

    6-K - VinFast Auto Ltd. (0001913510) (Filer)

    4/10/26 8:59:23 AM ET
    $VFS
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Oatly Group AB

    6-K - Oatly Group AB (0001843586) (Filer)

    4/10/26 7:30:54 AM ET
    $OTLY
    Packaged Foods
    Consumer Staples

    SEC Form PRE 14A filed by EverQuote Inc.

    PRE 14A - EverQuote, Inc. (0001640428) (Filer)

    4/8/26 4:30:25 PM ET
    $EVER
    Computer Software: Programming Data Processing
    Technology

    $BCYC
    $CMPS
    $CRM
    $EVER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Insana Giovanni

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    4/14/26 5:37:37 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Goldman Lea Rytz

    4 - PVH CORP. /DE/ (0000078239) (Issuer)

    4/14/26 4:16:04 PM ET
    $PVH
    Garments and Clothing
    Industrials

    SEC Form 4 filed by Olsson Fredrik

    4 - PVH CORP. /DE/ (0000078239) (Issuer)

    4/14/26 4:15:11 PM ET
    $PVH
    Garments and Clothing
    Industrials

    $BCYC
    $CMPS
    $CRM
    $EVER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 26, 2024 - FDA Roundup: March 26, 2024

    For Immediate Release: March 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA proposed a ban of electrical stimulation devices intended to reduce or stop self-injurious or aggressive behavior, a step rarely taken by the agency. The agency has determined that these devices present an unreasonable and substantial risk of

    3/26/24 3:38:14 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    $BCYC
    $CMPS
    $CRM
    $EVER
    Leadership Updates

    Live Leadership Updates

    View All

    Snowflake Appoints Jonathan Beaulier as Chief Revenue Officer

    Reaffirms Guidance for First Quarter and Full-Year of Fiscal 2027 Snowflake (NYSE:SNOW), the AI Data Cloud company, today announced that Jonathan Beaulier (JB), a Snowflake veteran who has been instrumental in driving Snowflake's growth since 2016, has been appointed as the company's Chief Revenue Officer, effective March 31, 2026. In his new role, Beaulier will be responsible for Snowflake's revenue and go-to-market teams, helping to lead Snowflake through its next chapter of growth. Mike Gannon, Snowflake's current CRO, has decided to leave the company for personal reasons. "JB has been a key driver of our success for the past ten years, and has consistently proven his ability to deli

    3/31/26 9:05:00 AM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    Tommy Hilfiger Welcomes American Football Icon Travis Kelce as Global Brand Ambassador and Creative Collaborator

    One of sport's biggest stars on and off the field, Travis Kelce steps into Tommy Hilfiger's world of Classic American Cool — in a series of campaigns, collaborations and events spanning F.A.M.E.S (Fashion, Art, Music, Entertainment and Sport). The multi-season partnership will showcase co-designed menswear and accessories refreshing "Prep Made Current" through Travis Kelce's vibrant lens. Tommy Hilfiger, which is part of PVH Corp. (NYSE:PVH), announces Travis Kelce — three-time Super Bowl champion and defining voice of his generation — as Global Brand Ambassador and creative collaborator. Inspired by its 40 years of collaborating with trailblazing figures across pop culture, Tommy Hilfi

    3/30/26 8:00:00 AM ET
    $PVH
    Garments and Clothing
    Industrials

    RESAAS Appoints Michael Dziekan as Director of Data Strategy

    VANCOUVER, BC, March 12, 2026 /CNW/ - RESAAS Services Inc. ("RESAAS") (TSXV:RSS) (OTCQB:RSASF), a leading provider of technology solutions for the real estate industry, is pleased to announce the appointment of Michael Dziekan as Director of Data Strategy. Dziekan will lead RESAAS' data strategy initiatives, focused on expanding the Company's data partnerships, enhancing its global real estate data infrastructure, driving new opportunities for data-driven products and services across the RESAAS platform.Dziekan brings extensive global experience in real estate data, analytics, a

    3/12/26 8:30:00 AM ET
    $IBM
    $SNOW
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    $BCYC
    $CMPS
    $CRM
    $EVER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Bicycle Therapeutics plc

    SC 13D/A - BICYCLE THERAPEUTICS PLC (0001761612) (Subject)

    12/17/24 6:46:27 PM ET
    $BCYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Bicycle Therapeutics plc

    SC 13G/A - BICYCLE THERAPEUTICS PLC (0001761612) (Subject)

    11/14/24 5:46:12 PM ET
    $BCYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by EverQuote Inc.

    SC 13G/A - EverQuote, Inc. (0001640428) (Subject)

    11/14/24 5:27:25 PM ET
    $EVER
    Computer Software: Programming Data Processing
    Technology

    $BCYC
    $CMPS
    $CRM
    $EVER
    Financials

    Live finance-specific insights

    View All

    EverQuote to Announce First Quarter 2026 Financial Results on May 4, 2026

    CAMBRIDGE, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (NASDAQ:EVER), a leading online insurance marketplace, today announced that it will report first quarter financial results after the market close on Monday, May 4, 2026. Management will host a conference call and webcast to discuss the Company's financial results, recent developments, and business outlook at 4:30 p.m. ET. What:EverQuote First Quarter 2026 Financial Results Conference Call  When:Monday, May 4, 2026  Time:4:30 p.m. ET  Live Call:US Toll Free: +1 (833) 461-5787All Other: +1 (585) 542-9983Conference ID: 161347139  Live Webcast and Replay:http://investors.everquote.com/   About EverQuote EverQuote (NASDAQ:EVE

    4/14/26 4:05:00 PM ET
    $EVER
    Computer Software: Programming Data Processing
    Technology

    PVH Corp. Reports 2025 Fourth Quarter Revenue and Earnings Above Guidance; Provides 2026 Outlook

    Delivered strong fourth quarter and finish to the year; fourth quarter revenue exceeded guidance, increasing 6% on a reported basis (flat in constant currency), with full year revenue in line with guidance, up 3% on a reported basis (up slightly in constant currency) Generated fourth quarter operating margin of 9.9% on a GAAP basis and 10.0% on a non-GAAP basis including an approximately 170 basis point negative impact of gross tariffs, exceeding guidance of approximately 9% Generated full year operating margin of 2.6% on a GAAP basis and 8.8% on a non-GAAP basis including an approximately 80 basis point negative impact of gross tariffs, exceeding guidance of approximately 8.5% Le

    3/31/26 4:15:00 PM ET
    $PVH
    Garments and Clothing
    Industrials

    Oatly to Report First Quarter 2026 Financial Results on April 29, 2026

    MALMÖ, Sweden, March 30, 2026 (GLOBE NEWSWIRE) -- Oatly Group AB (NASDAQ:OTLY), the world's original and largest oat drink company, will report financial results for the first quarter ended March 31, 2026, on Wednesday April 29, 2026 before the U.S. market opens. Oatly will host a conference call and webcast at 8:00 a.m. ET on the same day to discuss the results. The conference call and simultaneous live webcast can be accessed on Oatly's Investors website at https://investors.oatly.com under "Events." The webcast will be archived for 30 days. About Oatly We are the world's original and largest oat drink company. For over 30 years, we have exclusively focused on developing expertise arou

    3/30/26 7:00:00 AM ET
    $OTLY
    Packaged Foods
    Consumer Staples